lipid-regulating agent

This page covers all lipid-regulating agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting GPR109A.

Targets

GPR109A

Phase 3 pipeline (1)

• nicotine acid · GWT-TUD GmbH · Cardiovascular
  Nicotine acid, also known as niacin, primarily functions by reducing the production of very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) cholesterol in the liver.